The 17th Middle East
Best of San Antonio
Breast Cancer Symposium
Mövenpick – Al Khobar
27-28 Jan 2023
CHAIRMAN MESSAGE
CHAIRMAN MESSAGE
The Organizing and Scientific Committee of the 17th Middle East Best of San Antonio Breast Cancer Symposium , Khobar welcomes you to the 17th Middle East Best of SABCS™. This is also the 45th year of the San Antonio Breast Cancer Symposium (SABCS™) in San Antonio, Texas, USA. The symposium is the premier conference for basic, translational, and clinical cancer research professionals which provides a platform for interaction and communication among a wide range of researchers and healthcare professionals who has a special interest in breast cancer. It is well known for presenting the latest breast cancer data and updates from all over the world. The MESABCS allows healthcare professionals who are unable to travel to San Antonio, the opportunity to experience and discuss research and advances with colleagues and key opinion leaders. Attendees of the MESABCS program will receive the most current information on breast cancer research and advances that are changing clinical practice presented in the original format delivered at the meeting in San Antonio, Texas, this year.
This conference is accredited with CME hours by the Saudi Council for Health Specialties (SCFHS). On behalf of the Organizing and Scientific Committees of 17th MESABCS, we are delighted to invite you to become a part of this event and we will greatly appreciate your presence.
We look forward to welcoming you in Khoubar!
Sincerely,
Omalkhair Abulkhair, MD
Chairman, 17th Middle East Best of SABCS™
ABOUT THE CONFERENCE
The 17th Middle East Best of San Antonio Breast Cancer Symposium (17th MESABCS) allows healthcare professionals, the opportunity to experience and discuss the research and advances with colleagues and key opinion leaders. Hence, the attendees of the 17th MESABCS program will receive the most current information on breast cancer research presented in the original format delivered at the meeting in San Antonio in January 2022. Moreover, they will learn of the current advances in breast cancer research that are changing clinical practice for the benefit of the patients.
TARGET AUDIENCE
Technicians and Health Assistants, Laboratories and Medical Technology, Medical Oncology, Family Medicine, General surgery, Internal Medicine, Vascular Surgery, General Practice, Critical Care Medicine, Radiation Oncology, Diagnostic Radiology, Pediatric Surgery, Pediatric Oncology,Endocrinology, Nursing and Midwifery, Pharmacists and Pharmacy Technicians, Therapy and Rehabilitation, Health Education
MAIN TOPICS
Breast cancer screening – Triple negative breast cancer – Targeted therapy – Metastatic breast cancer – Loco-regional surgery – Radiation therapy – Supportive special issue
WORKSHOP
Breast pathology update
Nursing workshop
CONFERENCE OBJECTIVE
This Symposium is designed to provide state-of-the-art information on the experimental biology, etiology, prevention, diagnosis, and therapy of breast cancer and premalignant breast disease, to an international audience of academic and private physicians and researchers.
23 CME
Accredited
Scientific Committee
Associate Professor, Al Faisal University
Chairman for Breast Cancer Research,
King Abdullah International Medical Research
Dr. Omalkhair Aboalkhair
Consultant Oncoplastic Breast Surgeon
Head, Breast & Endocrine Surgery Section,
King Fahad Specialist Hospital
Dr. Jamila Al Azhri
Consultant Medical Oncologist
& Director Oncology Center, Prince
Sultan Medical Military City
Dr. Essam Murshid
MD, MSc, MME, FRCPC
Consultant, Gyne & Breast Pathologist,
King Abdulaziz Medical City of National Guard
Dr. Abdulmohsen Al Kushi
Consultant Medical Oncology,
Program Director of Adult Medical
Oncology, King Saud University
Dr. Sharif Kullab
Prof. of Clinical Oncology, Kasr Al-Ainy Center
of Clinical Oncology, Cairo University
Dr. Lobna Sedky
Consultant Medical Oncology
King Faisal Hospital
Dr. Taher Al Tuwaijri
Organizing Committee
Associate Professor, Al Faisal University
Chairman for Breast Cancer Research,
King Abdullah International Medical Research
Dr. Omalkhair Aboalkhair
Consultant Oncoplastic Breast Surgeon
Head, Breast & Endocrine Surgery Section,
King Fahad Specialist Hospital
Dr. Jamila Al Azhri
MD, FRCS (Edn)
Vice President for Administration & Finance
Dean, College of Medicine – Alfaisal University
Dr. Khaled Al Kattan
Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Dr. Rola Mufti
MESABCS Secretariat
Mrs. Donabel Bigtas-Castro
Account Manager, Mas Hub Est
Organizing Company
Mr. Loai Dawodi
Chairpersons
Consultant Medical Oncology, KFSH-Dammam.
Dr. Mohammad Rahhal
Prof of Clinical Oncology
Kasr Al Ainy Center of Clinical
Oncology, NEMROCK
Kasr Al Ainy Faculty of Medicine
Cairo University, Egypt
Dr. Lobna Sedky
Consultant Oncology,
The Unit of Hematology / Oncology Unit,
PSMMC – Riyadh
Dr. Huda Abdelkarim
MD, MRCP, FRCP, FACP
Director of Research & Innovation Center,
Burjeel Cancer Institute
President of Emirates Oncology
Adjunct Professor, University of Sharjah – UAE
Dr. Humaid Alshamsi
Medical Oncology,
King Fahad Specialist Hospital – Dammam
Dr. Leonidas Chelis
Consultant of Medical Oncology & Hematology,
Oncology Fellowship Program Director,
Johns Hopkins Aramco Healthcare
Dr. Abdurahaman Al Shehri
Professor of Clinical Oncology,
Head of Medical Research Center MASRI,
Ain Shams University – Egypt
President of BGICS
Dr. Hesham Al Ghazali
Associate Professor of Oncology
American & Canadian Board
of Medicine & Oncology,
King Abdulaziz University
Dr. Shadi Khayat
Consultant Medical Oncologist,
American Hospital Dubai – UAE
Dr. Fathi Azribi
Consultant & Associate Professor of Internal
Medicine & Medical Oncology
Department of Medicine,
King Abdulaziz University – Riyadh
Dr. Atlal Abusanad
Consultant & Head of Medical Oncology
Department, King Abdullah Medical City – Makkah
Assistant Professor of Medical Oncology,
Mansoura University – Egypt
Dr. Shereef Al Samany
Consultant Clinical Oncology,
International Medical Center – Jeddah
Dr. Ahmed Refae
Medical Oncology Consultant,
Prince Sultan Military Medical City – Riyadh
Assistant Professor of Oncology
Faculty of Medicine, Minia University – Egypt
Dr. Mervat Mahrous
Consultant Medical Oncologist
Dr. Mervat Al Saleh
FRCS, FBES
Professor of Surgery, King Saud University
Vice President, Saudi Society Breast
& Endocrine Surgery – Riyadh
Dr. Abdulaziz Alseif
Consultant Radiation Oncologist
King Abdulaziz University Hospital
Prof. Yasir Bahader
Chairman of Radiation Oncology Department,
King Fahad Specialist Hospital – Dammam
Dr. Ahlam Dohal
Consultant Oncoplastic Breast Surgeon
Head, Breast & Endocrine Surgery Section,
King Fahad Specialist Hospital – Dammam
Dr. Jamila Alazhari
Dr. Jihene Ayari
Chairman of Oncology Department,
Consultant Medical Oncologist,
King Fahad General Hospital – Madina
Dr. Majid Al Jahel
Prof. of Medical Oncology & Malignant Hematology,
Department Chair of The Medical Oncology Department
National Cancer Institute, Cairo University – Egypt
Prof. Ola Khorshid
Speakers
Assistant Professor At University Of Arkansas For Medical Sciences
American Board Of Internal Medicine, Hematology And Oncology
Consultant Medical Oncology King Fahad Specialist Hospital Dammam.
Dr. Ahmed Al Wabary
Medical oncology consultant at PSMMC in Riyadh program director adult medical oncology fellowship program
Dr. Aisha Alharbi
Consultant Medical Oncologist at King Fahad Medical city
Fellowship in Medical Oncology and undertook a clinical fellowship in Breast and Lung Oncology at Queen’s University, Canada
Dr. Abdullah Al Twairgi
Assistant Professor Consultant of hematology & oncology
Head of Clinical Trials Unit King Abdullaziz University
Dr. Marwan Al Hjeli
Consultant Medical Oncologist
Director Oncology Center Prince Sultan Medical Military City
Riyadh – Kingdom of Saudi Arabia
Dr. Essam Murshid
Director, Oncology Center
Senior Consultant, Oncology
Executive Director, Research Center
IMC – Jeddah – Saudi Arabia
Prof. Ezzeldin M. Ibrahim
Professor of Medicine
King Saud medical city | KSMC · Department of
Oncology
Prof. Jean-Marc Nabholtz
Pr Joseph Gligorov
Institut Universitaire de Cancérologie AP-HP Sorbonne Université
Prof. Joseph Gligorov
Consultant Medical Oncology Tawam Hospital – SEHA – UAE
American Board of Internal Medicine
Hematology and Medical oncology
Dr. Aydah Alawadhi
HEAD OF MEDICAL ONCOLOGY
PSMMC CONSULTANT OF MEDICAL ONCOLOGY
Dr. Taleb Bohlaiqa
Consultant medical oncology
Executive Director of Medical Administration
King Fahad Specialist Hospital Dammam, Saudi Arabia
Dr. Hulayel Alharbi
Professor and Chairman, Department of Medicine
Chief Medical Officer and Deputy Director General
King Hussein Cancer Center Amman, Jordan
Dr. Hikmat Abdel-Razeq
President of Saudi Oncology Society
Section Head of Medical Oncology
National Guard Health Affairs, Jeddah
Dr. Meteb Alfoheidi
Consultant Medical Oncology
King Abdulaziz medical city
Dr. Ahmed Alshehri
Consultant hematology and oncology
Faculty of Medicine
King Saud University
Dr. Khaled Al Saleh
Professor of Medicine, Al Faisal University
Consultant Medical Oncologist
King Faisal Specialist Hospital & Research Centre
Dr. Jamal Zekri
Consultant Radiation Oncologist
King Fahad Specialist Hospital Dammam
Dr. Taghreed Alhindi
Head of Radiation Oncology
PSMMC – Riyadh
Dr. Abdulaziz Alhamad
MBBS, MRCSI, MRCSEd, DBRM, FEBS,FRCSEd, MD
Consultant Oncoplastic Breast Surgeon
Dr. Yazan Masannat
Consultant Oncoplastic Breast Surgeon
MBBS, MS, FRCS ED, DM, FRCS
Dr. Amit Agrawal
Prof. & Head, Hematology Oncology
Director, Breast Center of Excellence, NKBCI
American University of Beirut Medical Center
Dr. Nagi Alsaghir
Professor of Clinical Oncology Alexandria School of Medicine Egypt
Member: ASCO expert Panel for metastatic breast cancer treatment guidelines Member: ASCO International Affairs Committee
Dr. Alaa Kandil
Consultant Medical Oncologist , King Fahad Medical City – Riyadh
Clinical Oncology, Genitourinary Cancer, Breast Cancer and Gynecologic Oncology.
Dr. Bassam Basulaiman
Consultant Medical Oncologist
King Fahad Specialist Hospital
Dammam, Saudi Arabia
Dr. Ahmed Alfaraj
Consultant Medical Oncologist
Head of Breast Cancer Unit
Kuwait Cancer Control Center – Kuwait
Dr. Faisal Altakriti
Adult Medical Oncologist ,MD., MSc
King Abdulaziz Medical City – NGHA- Riyadh
Dr. Sadal Refae
Chairman of Medical Oncology Department
King Fahad Specialist Hospital – Dammam
Dr. Fahad Ibn Shamsah
Professor of Medicine (Medical Oncology), University Tunis El Manar – Faculty of Medicine Tunis
Head, Department of Medical Oncology Abderrahmen Mami Hospital, Ariana, Tunisia
Dr. Hamouda Boussen
Consultant Medical Oncology
King Faisal Hospital Riyadh
Dr. Taher Al-Tweigeri
Consultant Breast, Gynecologic and liver Pathologist
Section Head of Anatomic Pathology
King Fahad Specialist Hospital Dammam
Dr. Miral Mashhour
Consultant, Gynae & Breast pathologist,
King Abdulaziz Medical City
National Guard , Riyadh
Dr. Abdelmohosen Alkushi
Consultant Medical Oncology – Oncology Center
King Abdulaziz Medical City for National Guard
Riyadh, Saudi Arabia
Dr. Amin Tejani
Consultant Adult Medical Oncology
King Fahd Specialist Hospital, Dammam, Saudi Arabia
Dr. Ehab Hassan
Chairman of Kasr Al-Ainy School of Oncology (KASO)
Department of Oncology, Faculty of Medicine, Cairo University.
Professor of Clinical Oncology, Cairo University, Cairo, Egypt
Dr. Hamdy AbdelAzim
Consultant, medical oncologist Breast cancer Centre
KFSH&RC Riyadh
Dr. Mashari Al Zahrani
Consultant Medical Oncologist
Chairman of Medical Oncology,
Department, Comprehensive Cancer Center
King Fahad Medical City, Riyadh
Dr. Ali Alfaqih
Consultant Medical Oncology
King Saud Medical City